Download - Hemodynamics: essentials for future TAVR and mitral valve disease

Transcript
Page 1: Hemodynamics: essentials for future TAVR and mitral valve  disease

Hemodynamics: essentials for future TAVR and mitral valve disease

Morton J. Kern, MDProfessor of Medicine

Chief of CardiologyAssociate Chief CardiologyUniversity California Irvine

Orange, California

Page 2: Hemodynamics: essentials for future TAVR and mitral valve  disease

Etiology of Aortic Stenosis From the Euro Heart Survey

Goldbarg, S. H. et al. J Am Coll Cardiol 2007;50:1205-1213

Page 3: Hemodynamics: essentials for future TAVR and mitral valve  disease

J Am Coll Cardiol. 2012;60(3):169-180.

Pathophysiology of AS

Page 4: Hemodynamics: essentials for future TAVR and mitral valve  disease

Tri/MV valves open

Pa/Ao valves are closed

Pa/Ao valves open

Tri/MV valves close

Pa/Ao valves close

Tri/MV valves opensystole

=Valve action

Page 5: Hemodynamics: essentials for future TAVR and mitral valve  disease

Mechanism of AS: LV-Ao Gradient

Consequences of LV-Ao Gradient:

1. late peaking Systolic murmur

2. Single A23. Slow pulse upstroke

Page 6: Hemodynamics: essentials for future TAVR and mitral valve  disease

BAMC Case #3117: Patient: 61 yo maleDx: 3V CAD filter: 50 Hz/ sample 250 Hz

Pre ContrastNormal LV and Aortic Pressure Fluid-filled system micromanometer transducers Fluid filled, FA sheath

Page 7: Hemodynamics: essentials for future TAVR and mitral valve  disease

P-P gradMean Grad

Peak instantaneous vs P-P

Unshifted=larger Grad

LV

Fusberg and Feldman T, Cath and CV Int 53:553;2001

Hemodynamic Technique

Page 8: Hemodynamics: essentials for future TAVR and mitral valve  disease

Techniques for Aortic Valve Gradient Measurement

• Single Catheter LV-Ao pullback• LV and Femoral Sheath• LV and Long aortic sheath• Bilateral femoral access• Double-lumen pigtail catheter• Transeptal LV access with ascending Ao• Pressure Guidewire with ascending Ao• Multi-transducer micromanometer catheters

Fusberg and Feldman T, Cath and CV Int 53:553;2001

Page 9: Hemodynamics: essentials for future TAVR and mitral valve  disease

Calculating Aortic Valve Area• AVA: Gorlin equation

• AVA: Hakke formula (“poor man’s Gorlin”)– Assumes HR*SEP*44.3 = 1000 in most patients– Valid for HR ~65-100

AVA = cardiac output (L/min)/√Peak-Peak Pressures

Page 10: Hemodynamics: essentials for future TAVR and mitral valve  disease

Grading Severity of Aortic Stenosis

AVA AVA IndexAortic Stenosis (cm2) (cm2/m2)

Mild >1.5 >0.9

Moderate 1.1-1.5 >0.6-0.9

Severe <0.8-1.0 <0.4-0.6

Page 11: Hemodynamics: essentials for future TAVR and mitral valve  disease
Page 12: Hemodynamics: essentials for future TAVR and mitral valve  disease
Page 13: Hemodynamics: essentials for future TAVR and mitral valve  disease

Hemodynamic Differentiation of LVOT Obstruction

AS HOCM

3 Differentiating featuresa. Aortic upstrokeb. Pulse pressurec. Contour –spike/dome

Page 14: Hemodynamics: essentials for future TAVR and mitral valve  disease

Low Gradient, Low EF AS?

LVEF 25%P-P gradient 30mmHgCO = 3.2l/m FickAVA = 0.7cm2

Page 15: Hemodynamics: essentials for future TAVR and mitral valve  disease

Base 10 Dob+Pace 80 20 Dob + Pace 95

Dobutamine challenge for LG AS

P-P = 50mmHgCO = 4.2l/m

AVA = 0.6cm2

Page 16: Hemodynamics: essentials for future TAVR and mitral valve  disease

Grayburn, P. A. Circulation 2006;113:604-606

What should you do with Symptomatic AS patient, low gradient, low flow? The Dobutamine Challenge

AVA = 0.7cm2

AVA = 1.0cm2

AVA = 1.5cm2

Fixed area

Page 17: Hemodynamics: essentials for future TAVR and mitral valve  disease

Chiam, P. T.L. et al. J Am Coll Cardiol Intv 2008;1:341-350

Edwards-Sapien PHVCoreValve PHV

Page 18: Hemodynamics: essentials for future TAVR and mitral valve  disease
Page 19: Hemodynamics: essentials for future TAVR and mitral valve  disease
Page 20: Hemodynamics: essentials for future TAVR and mitral valve  disease

Pre- Post 26mm Sapien Edwards

Anachrotic shoulder, dichrotic notch

Diastolic dysfunction?Delayed upslope

Page 21: Hemodynamics: essentials for future TAVR and mitral valve  disease

AS+AI

Page 22: Hemodynamics: essentials for future TAVR and mitral valve  disease
Page 23: Hemodynamics: essentials for future TAVR and mitral valve  disease

Normal LA and LV diastolic pressures LA-LV Diastolic Gradient

Page 24: Hemodynamics: essentials for future TAVR and mitral valve  disease

PCW does not always equal LA

Page 25: Hemodynamics: essentials for future TAVR and mitral valve  disease

Hemodynamics and Doppler Echo findings before MVBP

Page 26: Hemodynamics: essentials for future TAVR and mitral valve  disease
Page 27: Hemodynamics: essentials for future TAVR and mitral valve  disease

Hemodynamic and Doppler Echo findings after MVBP

Page 28: Hemodynamics: essentials for future TAVR and mitral valve  disease
Page 29: Hemodynamics: essentials for future TAVR and mitral valve  disease

Hemodynamics for Structrual Heart Disease

Low Gradient ASComplications of AVP – AIAS vs. HOCMMitral Regurgitation after MVP for MSDiastolic CHF – constrictive v RestrictiveTamponade

For your own review consider Intracardiac Shunts